OHRP vs. CMRA, GRI, SPRC, EVLO, LSDI, PBLA, HSTO, SBFM, NBSE, and EVFM
Should you be buying OHR Pharmaceutical stock or one of its competitors? The main competitors of OHR Pharmaceutical include Comera Life Sciences (CMRA), GRI Bio (GRI), SciSparc (SPRC), Evelo Biosciences (EVLO), Lucy Scientific Discovery (LSDI), Panbela Therapeutics (PBLA), Histogen (HSTO), Sunshine Biopharma (SBFM), NeuBase Therapeutics (NBSE), and Evofem Biosciences (EVFM). These companies are all part of the "medical" sector.
OHR Pharmaceutical (NASDAQ:OHRP) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.
OHR Pharmaceutical has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.
OHR Pharmaceutical received 295 more outperform votes than Comera Life Sciences when rated by MarketBeat users.
OHR Pharmaceutical has a net margin of 0.00% compared to Comera Life Sciences' net margin of -904.00%. Comera Life Sciences' return on equity of 0.00% beat OHR Pharmaceutical's return on equity.
10.7% of OHR Pharmaceutical shares are owned by institutional investors. 12.5% of OHR Pharmaceutical shares are owned by company insiders. Comparatively, 8.9% of Comera Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, OHR Pharmaceutical's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.
OHR Pharmaceutical has higher earnings, but lower revenue than Comera Life Sciences.
Summary
OHR Pharmaceutical beats Comera Life Sciences on 7 of the 9 factors compared between the two stocks.
Get OHR Pharmaceutical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OHRP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OHRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OHR Pharmaceutical Competitors List
Related Companies and Tools
